mRNA technology Current Affairs, GK & News
On September 28, 2021, Pfizer Inc. announced that the first batch of participants have been dosed with the single dose quadrivalent mRNA vaccine in a Phase 1 clinical trial. Highlights Under the phase 1 trial, safety, tolerability, and immunogenicity of the single dose quadrivalent mRNA vaccine will be studied against influenza in healthy adults. mRNA ..
Category: Science & Technology Current Affairs